Literature cited
L. V. Azaryan, S. A. Avetisyan, N. E. Akopyan, et al., Khim.-farm. Zh., No. 8, 55–58 (1978).
L. V. Azaryan, O. L. Mndzhoyan, S. A. Avetisyan, et al., ibid., No. 7, 808–813 (1983).
M. D. Mashkovskii, Recent Advances in Neuropharmacology [in Russian], Leningrad (1982), pp. 107–111.
J. Bures and O. Buresova, J. Comp. Physiol. Psychol.,56, 286–272 (1963).
K. H. Dudly and D. L. Bius, J. Org. Chem.,34, No. 4, 1133–1136 (1969).
D. W. Gallager, P. Mallorga, and J. F. Tallman, Brain Res.,189, 209–220 (1980).
C. Guizgea, H. Mouravie, and F. Lesuisse, Neuro-psychopharmacology, Oxford (1978), pp. 1623–1631.
W. Haefel, L. Pieri, and R. Schafner, General Pharmacology and Neuropharmacology of Benzodiazepine Derivatives, Berlin (1981), p. 262.
Martindale, The Extra Pharmacopeia, 28th Edn., London (1985), p. 1251.
J. V. Millichap, Physiological Pharmacology,2B, 97–143 (1965).
W. P. Tsun-Hon and T. Sau-Fun, Jpn. J. Pharmacol.,49, No. 3, 309–315 (1989).
Author information
Authors and Affiliations
Additional information
Translated from Khimiko-farmatsevticheskii Zhurnal, Vol. 25, No. 3, pp. 32–34, March, 1991.
Rights and permissions
About this article
Cite this article
Dzhagatspanyan, I.A., Azaryan, L.V., Melikyan, G.G. et al. 3,5-Dimethyl-5-p-alkoxyphenylhydantoins and their neurotropic properties. Pharm Chem J 25, 181–184 (1991). https://doi.org/10.1007/BF00772018
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00772018